Average Co-Inventor Count = 8.50
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (17 from 1,535 patents)
2. Macrogenics, Inc. (3 from 130 patents)
3. Cdr-life Ag (1 from 4 patents)
4. Ose Immmnotherapeatics Sa (1 from 1 patent)
17 patents:
1. 12344663 - Anti-C3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases
2. 12312405 - Anti-PD-1 antibodies
3. 12275798 - Tri-specific binding molecules
4. 12173083 - Multi-specific binding proteins for cancer treatment
5. 12146000 - Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer
6. 11884744 - Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof
7. 11795219 - Antibody molecules for cancer treatment
8. 11732045 - Multi-specific binding proteins for cancer treatment
9. 11661458 - Anti-NRP1A antibodies and their uses for treating eye or ocular diseases
10. 11572412 - Anti-SIRP-alpha antibodies
11. 11396539 - Anti-ANGPT2 antibodies
12. 11370818 - Anti-BAFF antibodies
13. 11332541 - Multi-specific binding proteins for cancer treatment
14. 10844138 - Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof
15. 10377804 - Anti-BAFF antibodies